Two television commercials for Bayer AG´s birth control pill Yaz give a misleading impression of its benefits, the U.S. health regulators warned the company in a letter.

The ads wrongly suggest the pills are approved for relieving premenstrual syndrome, the FDA said, and also minimize the drug´s risks.

Bayer spokeswoman Rose Talarico said the company will stop running the only one of the two ads currently in use. The other campaign ended in 2007.

Yaz is cleared for a condition called premenstrual dysphoric disorder (PMDD), which causes anxiety, tension, persistent anger and other symptoms. The commercial no longer being broadcast featured women singing "We're not gonna take it" and kicking, punching and pushing balloons with words such as "irritability," "moodiness" and "bloating," which are symptoms common with PMS, for which the pill is not approved.

Bayer will pull the current ad and work with the FDA regarding other promotions for Yaz, Talarico said.
The FDA also said both commercials "suggest that Yaz is approved for acne of all severities when this is not the case." In addition, the FDA said the ads distracted viewers with fast-moving images and background music, while information about potential side effects was described (such as blood clots).